Patient Guide: REMASTer: REcurrent Brain Metastases After SRS Trial

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05124912
Status: 🟢 Enrolling Now
Condition: Brain Metastases, Radiation Necrosis, Recurrent Tumor, Recurrent Metastases
Phase: NA

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Chicago, Illinois
  • • Baltimore, Maryland
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

REMASTer: REcurrent Brain Metastases After SRS Trial - Join Clinical Trial NCTNCT05124912

How to Join This Clinical Trial - NCTNCT05124912

Learn how to participate in this NA trial studying an investigational therapy for Brain Metastases, Radiation Necrosis, Recurrent Tumor, Recurrent Metastases. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Brain Metastases, Radiation Necrosis, Recurrent Tumor, Recurrent Metastases. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Brain Metastases, Radiation Necrosis, Recurrent Tumor, Recurrent Metastases
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05124912 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90095 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: RECRUITING

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: RECRUITING

Clinical Research Site

Saint Louis, Missouri 63130 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27710 - United States

Status: RECRUITING

Clinical Research Site

Winston-Salem, North Carolina 27157 - United States

Status: RECRUITING

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: RECRUITING

Clinical Research Site

Kettering, Ohio 45429 - United States

Status: RECRUITING

Clinical Research Site

Milwaukee, Wisconsin 53226 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Brain Metastases, Radiation Necrosis, Recurrent Tumor, Recurrent Metastases:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships